Evidence map›Paper›PMID 41982041›Full record

ArticleThe Laryngoscope2026

Long-Term Voice Outcomes After Trans-Oral Resection of Early Glottis Carcinoma.

Peak Woo, Anahita Nourmahnad, Benjamin M Laitman

Abstract read
In one paragraph

Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peak WooDepartment of Otolaryngology Head and Neck Surgery, The Icahn School of Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0003-0144-5178
Anahita NourmahnadDepartment of Otolaryngology Head and Neck Surgery, The Icahn School of Medicine, New York, New York, USA.
Benjamin M LaitmanDepartment of Otolaryngology Head and Neck Surgery, The Icahn School of Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0002-9582-6088

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSurvival after trans-oral laser microsurgery (TLM) for glottic carcinoma is excellent. However, the voice quality after TLM remains unclear. This study examines voice outcomes following different surgical procedures. STUDY

designA retrospective study of voice outcomes (GRBAS, VHI-10, CSID scores) after TLM. MATERIAL AND

methodsPatients undergoing TLM were studied. We collected the Voice Handicap Index (VHI-10), acoustic analysis (Cepstral Spectral Peak Prominence, CSPP score), and GRBAS rating score. These data were correlated with cancer stage and ELS (surgery type).

resultsWe studied 102 patients (86 males, 16 females; median age 74). There were 51 type I and 27 type Va resections. The rest underwent types II, III, IV, Vb, VI, and open vertical hemilaryngectomy surgery. The median follow-up time was 5.2 years. The median VHI-10 score was 7.5 (normal < 10). The median CSID score was 27.5 (mild = 20-40). The Average GRBAS score was G1.5, R1, B1, A0, S1.5 (mild = 1, moderate = 2). There was a correlation between the CSID score and the type of cordectomy and surgical stage. There was a statistical difference in Type I ELR resection outcomes compared with all other types in voice outcome (Cohen's d-value > 0.5).

conclusionsPatients often rate their VHI as normal, while objective and perceptual raters rate voices after TLM as showing mild to moderate dysphonia. This low VHI score may be due to cancer survivorship. Understanding the patient experience after TLM surgery and knowing the extent of surgery on voice outcomes can help better counsel patients undergoing TLM. LEVEL OF EVIDENCE: 3:

Indexed as

CarcinomaGlottisLaryngeal NeoplasmsLaryngectomyLaser TherapyMicrosurgeryVoice QualityAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesCO2 laser surgerydysphonialaryngeal cancervoice handicapvoice quality

Identifiers

PMID41982041
PMCPMC13460503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.